Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Putative aquaporin-7B (AQP7B) is a predicted member of the aquaporin family, specifically an aquaglyceroporin, which are integral membrane proteins mediating water and glycerol transport across the plasma membrane[4][3]. There is little to no evidence of functional characterization, clinical relevance, or disease association for AQP7B in scientific literature or major protein databases. Its existence is predicted based on gene and protein sequence similarity, but experimental confirmation and biological role, if any, remain undetermined[4]. This distinguishes it from well-characterized aquaporin family members like aquaporin-7 (AQP7)[2][3]. AQP7B (putative aquaporin-7B) is a predicted aquaporin protein with no established functional, clinical, or therapeutic relevance. It should not be confused with AQP7, which is a validated transporter. There is something wrong with considering AQP7B as a canonical, actionable target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Putative aquaporin-7B (AQP7B).